Index by author

June 01 1999; volume 48 issue 6

A

  1. Ashcroft, F M

    1. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
      R Ashfield, F M Gribble, S J Ashcroft and F M Ashcroft
      Diabetes 1999 Jun; 48 (6): 1341-1347. https://doi.org/10.2337/diabetes.48.6.1341

  2. Ashcroft, S J

    1. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
      R Ashfield, F M Gribble, S J Ashcroft and F M Ashcroft
      Diabetes 1999 Jun; 48 (6): 1341-1347. https://doi.org/10.2337/diabetes.48.6.1341

  3. Ashfield, R

    1. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
      R Ashfield, F M Gribble, S J Ashcroft and F M Ashcroft
      Diabetes 1999 Jun; 48 (6): 1341-1347. https://doi.org/10.2337/diabetes.48.6.1341

  4. Avogaro, A

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  5. Axelin, T

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

B

  1. Barucci, N

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  2. Baumgartner-Parzer, S

    1. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

  3. Beck-Nielsen, H

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  4. Bell, K

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  5. Bergman, J

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  6. Bertuzzi, F

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  7. Beylot, M

    1. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.
      V Large and M Beylot
      Diabetes 1999 Jun; 48 (6): 1251-1257. https://doi.org/10.2337/diabetes.48.6.1251

  8. Brownlee, M

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  9. Brun, S

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  10. Burcelin, R

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

C

  1. Campeau, L

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  2. Canner, J

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  3. Capristo, E

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  4. Carmona, M C

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  5. Castagneto, M

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  6. Ceolotto, G

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  7. Cerasi, E

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  8. Chan, A

    1. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
      Y L Kao, K Donaghue, A Chan, J Knight and M Silink
      Diabetes 1999 Jun; 48 (6): 1338-1340. https://doi.org/10.2337/diabetes.48.6.1338

  9. Charron, M J

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

  10. Cline, G W

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  11. Cressman, M

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

D

  1. De Haan, C H

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  2. De Leeuw, P W

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  3. Del Prato, S

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  4. Domanski, M

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  5. Donaghue, K

    1. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
      Y L Kao, K Donaghue, A Chan, J Knight and M Silink
      Diabetes 1999 Jun; 48 (6): 1338-1340. https://doi.org/10.2337/diabetes.48.6.1338

E

  1. Edelstein, D

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  2. Esenabhalu, V E

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

F

  1. Ferrannini, E

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  2. Fleischhacker, E

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

  3. Friedman, J M

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

G

  1. Gallo, A

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  2. Gasbarrini, G

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  3. Gastaldelli, A

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  4. Geller, N

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  5. Giralt, M

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  6. Goodyear, L J

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  7. Graier, W F

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323
    2. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

  8. Greco, A V

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  9. Gribble, F M

    1. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
      R Ashfield, F M Gribble, S J Ashcroft and F M Ashcroft
      Diabetes 1999 Jun; 48 (6): 1341-1347. https://doi.org/10.2337/diabetes.48.6.1341

  10. Griffin, M E

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  11. Gross, D J

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

H

  1. Haaparanta, M

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  2. Hämäläinen, H

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  3. Hamulyak, K

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  4. Hartikainen, J E

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  5. Havel, P J

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

  6. He, C

    1. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.
      C He, J Sabol, T Mitsuhashi and H Vlassara
      Diabetes 1999 Jun; 48 (6): 1308-1315. https://doi.org/10.2337/diabetes.48.6.1308

  7. Henriksen, F L

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  8. Herd, A

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  9. Hickey, A

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  10. Hirayama, I

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  11. Holzmann, S

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

  12. Hoogwerf, B J

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  13. Houben, A J

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  14. Hunninghake, D B

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  15. Huvers, F C

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

I

  1. Iglesias, R

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  2. Iida, H

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  3. Izumi, T

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

J

  1. Ju, Q

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  2. Jürgens, G

    1. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

K

  1. Kaiser, N

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  2. Kamohara, S

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

  3. Kao, Y L

    1. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
      Y L Kao, K Donaghue, A Chan, J Knight and M Silink
      Diabetes 1999 Jun; 48 (6): 1338-1340. https://doi.org/10.2337/diabetes.48.6.1338

  4. Klip, A

    1. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle.
      J M Mathoo, Z Q Shi, A Klip and M Vranic
      Diabetes 1999 Jun; 48 (6): 1281-1288. https://doi.org/10.2337/diabetes.48.6.1281

  5. Knatterud, G L

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  6. Knight, J

    1. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
      Y L Kao, K Donaghue, A Chan, J Knight and M Silink
      Diabetes 1999 Jun; 48 (6): 1338-1340. https://doi.org/10.2337/diabetes.48.6.1338

  7. Knuuti, J

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  8. Koidl, B

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

  9. Korbutt, G S

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  10. Kostner, G M

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323
    2. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

  11. Kraegen, E W

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  12. Krogh, L N

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  13. Kubo, S K

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  14. Kuwano, H

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

L

  1. Laakso, M

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  2. Laitinen, T

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  3. Länsimies, E A

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  4. Large, V

    1. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.
      V Large and M Beylot
      Diabetes 1999 Jun; 48 (6): 1251-1257. https://doi.org/10.2337/diabetes.48.6.1251

  5. Lee, D

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  6. Leibowitz, G

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  7. Li, J

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

  8. Luotolahti, M

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

M

  1. Mäki, M

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  2. Mampel, T

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  3. Marcucci, M J

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  4. Marshak, S

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  5. Mathoo, J M

    1. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle.
      J M Mathoo, Z Q Shi, A Klip and M Vranic
      Diabetes 1999 Jun; 48 (6): 1281-1288. https://doi.org/10.2337/diabetes.48.6.1281

  6. Melloul, D

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  7. Mingrone, G

    1. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
      G Mingrone, F L Henriksen, A V Greco, L N Krogh, E Capristo, A Gastaldelli, M Castagneto, E Ferrannini, G Gasbarrini and H Beck-Nielsen
      Diabetes 1999 Jun; 48 (6): 1258-1263. https://doi.org/10.2337/diabetes.48.6.1258

  8. Miola, M

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  9. Mitsuhashi, T

    1. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.
      C He, J Sabol, T Mitsuhashi and H Vlassara
      Diabetes 1999 Jun; 48 (6): 1308-1315. https://doi.org/10.2337/diabetes.48.6.1308

N

  1. Nagamachi, Y

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  2. Niskanen, L K

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  3. Nuutila, P

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

P

  1. Posch, K

    1. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

R

  1. Rabinovitch, A

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  2. Rajotte, R V

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

S

  1. Sabol, J

    1. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.
      C He, J Sabol, T Mitsuhashi and H Vlassara
      Diabetes 1999 Jun; 48 (6): 1308-1315. https://doi.org/10.2337/diabetes.48.6.1308

  2. Sartori, M

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  3. Schaper, N C

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  4. Schouten, H

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  5. Schwartz, M W

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

  6. Seeley, R J

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

  7. Semplicini, A

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  8. Shi, Z Q

    1. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle.
      J M Mathoo, Z Q Shi, A Klip and M Vranic
      Diabetes 1999 Jun; 48 (6): 1281-1288. https://doi.org/10.2337/diabetes.48.6.1281

  9. Shulman, G I

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  10. Silink, M

    1. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
      Y L Kao, K Donaghue, A Chan, J Knight and M Silink
      Diabetes 1999 Jun; 48 (6): 1338-1340. https://doi.org/10.2337/diabetes.48.6.1338

  11. Simecek, S

    1. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

  12. Sindelar, D K

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

  13. Skrabal, F

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

  14. Socci, C

    1. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.
      S Marshak, G Leibowitz, F Bertuzzi, C Socci, N Kaiser, D J Gross, E Cerasi and D Melloul
      Diabetes 1999 Jun; 48 (6): 1230-1236. https://doi.org/10.2337/diabetes.48.6.1230

  15. Spitaler, M

    1. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
      E Fleischhacker, V E Esenabhalu, M Spitaler, S Holzmann, F Skrabal, B Koidl, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1323-1330. https://doi.org/10.2337/diabetes.48.6.1323

  16. Strynadka, K

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

  17. Suarez-Pinzon, W

    1. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
      A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, G S Korbutt and R V Rajotte
      Diabetes 1999 Jun; 48 (6): 1223-1229. https://doi.org/10.2337/diabetes.48.6.1223

T

  1. Takala, T O

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

  2. Takeuchi, T

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  3. Tamemoto, H

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  4. Tannenbaum, G S

    1. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
      R Burcelin, S Kamohara, J Li, G S Tannenbaum, M J Charron and J M Friedman
      Diabetes 1999 Jun; 48 (6): 1264-1269. https://doi.org/10.2337/diabetes.48.6.1264

  5. Trevisan, R

    1. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
      G Ceolotto, A Gallo, M Miola, M Sartori, R Trevisan, S Del Prato, A Semplicini and A Avogaro
      Diabetes 1999 Jun; 48 (6): 1316-1322. https://doi.org/10.2337/diabetes.48.6.1316

  6. Turpeinen, A K

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245

U

  1. Uusitupa, M I

    1. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
      A K Turpeinen, T O Takala, P Nuutila, T Axelin, M Luotolahti, M Haaparanta, J Bergman, H Hämäläinen, H Iida, M Mäki, M I Uusitupa and J Knuuti
      Diabetes 1999 Jun; 48 (6): 1245-1250. https://doi.org/10.2337/diabetes.48.6.1245
    2. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

V

  1. Vauhkonen, I K

    1. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
      T Laitinen, I K Vauhkonen, L K Niskanen, J E Hartikainen, E A Länsimies, M I Uusitupa and M Laakso
      Diabetes 1999 Jun; 48 (6): 1295-1299. https://doi.org/10.2337/diabetes.48.6.1295

  2. Villarroya, F

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  3. Viñas, O

    1. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
      S Brun, M C Carmona, T Mampel, O Viñas, M Giralt, R Iglesias and F Villarroya
      Diabetes 1999 Jun; 48 (6): 1217-1222. https://doi.org/10.2337/diabetes.48.6.1217

  4. Vlassara, H

    1. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.
      C He, J Sabol, T Mitsuhashi and H Vlassara
      Diabetes 1999 Jun; 48 (6): 1308-1315. https://doi.org/10.2337/diabetes.48.6.1308

  5. Vranic, M

    1. Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle.
      J M Mathoo, Z Q Shi, A Klip and M Vranic
      Diabetes 1999 Jun; 48 (6): 1281-1288. https://doi.org/10.2337/diabetes.48.6.1281

W

  1. Waness, A

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  2. Wang, J

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237

  3. Wascher, T C

    1. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.
      K Posch, S Simecek, T C Wascher, G Jürgens, S Baumgartner-Parzer, G M Kostner and W F Graier
      Diabetes 1999 Jun; 48 (6): 1331-1337. https://doi.org/10.2337/diabetes.48.6.1331

  4. White, C

    1. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
      B J Hoogwerf, A Waness, M Cressman, J Canner, L Campeau, M Domanski, N Geller, A Herd, A Hickey, D B Hunninghake, G L Knatterud and C White
      Diabetes 1999 Jun; 48 (6): 1289-1294. https://doi.org/10.2337/diabetes.48.6.1289

  5. White, M F

    1. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
      M E Griffin, M J Marcucci, G W Cline, K Bell, N Barucci, D Lee, L J Goodyear, E W Kraegen, M F White and G I Shulman
      Diabetes 1999 Jun; 48 (6): 1270-1274. https://doi.org/10.2337/diabetes.48.6.1270

  6. Wilkinson, C W

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

  7. Wolffenbuttel, B H

    1. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
      F C Huvers, P W De Leeuw, A J Houben, C H De Haan, K Hamulyak, H Schouten, B H Wolffenbuttel and N C Schaper
      Diabetes 1999 Jun; 48 (6): 1300-1307. https://doi.org/10.2337/diabetes.48.6.1300

  8. Woods, S C

    1. Low plasma leptin levels contribute to diabetic hyperphagia in rats.
      D K Sindelar, P J Havel, R J Seeley, C W Wilkinson, S C Woods and M W Schwartz
      Diabetes 1999 Jun; 48 (6): 1275-1280. https://doi.org/10.2337/diabetes.48.6.1275

Y

  1. Yokota, H

    1. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2.
      I Hirayama, H Tamemoto, H Yokota, S K Kubo, J Wang, H Kuwano, Y Nagamachi, T Takeuchi and T Izumi
      Diabetes 1999 Jun; 48 (6): 1237-1244. https://doi.org/10.2337/diabetes.48.6.1237
Back to top

In this Issue

June 1999, 48(6)
Sign up to receive current issue alerts
View Selected Citations (0)